January 24th 2025
A study found that 2 weeks of maternal bed rest significantly increases fetal weight and growth metrics in small for gestational age fetuses.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
In light of the FDA's black box warning about potential bone loss in teenagers, how do you counsel teenagers about this highly effective birth control method? Recommendations from the World Health Organization provide a practical, evidence-based approach to weighing the risks.
Read More
Grand Rounds: Part 1: Cervical cancer guidelines: Making sense of the screening intervals
April 1st 2006If there's really been such a sea change in how and when to screen for cervical cancer, when are clinicians going to take the plunge and start applying new recommendations? An expert comes to the rescue by sifting through the new ACS and ACOG guidelines, to help you put them into practice.
Read More
Does subclinical hypothyroidism really affect pediatric IQ?
March 1st 2006Apparently not. In a FASTER-related study, researchers from seven centers who studied more than 10,000 patients concluded that the association between subclinical hypothyroidism and lower pediatric IQ does not appear to result from obstetric factors. The finding is of special note given controversy on this question raised by recent studies.
Read More
NICHD finding: the nail in the coffin for fetal pulse oximetry?
March 1st 2006Is fetal pulse oximetry a waste of time? Riveting results from an important trial presented at the 26th annual SMFM meeting in Miami in February suggest just that?and seemingly shatter the whole premise behind fetal pulse oximetry: that it might either improve perinatal outcome or lower cesarean delivery rates.
Read More
Sign Out: Maternal and newborn mortality: the silent tragedies
January 1st 2006No issue is more central to global well-being than the health of mothers and their babies. Every individual, every family, every community at some point or another is intimately involved with pregnancy and the success of childbirth. And yet every day, 1,600 women and more than 10,000 newborns die due to complications that could have been prevented.
Read More
U/S Clinics: Putting the FASTER results into clinical practice
January 1st 2006Counseling patients on screening for Down syndrome has long been a challenge. Findings from the FASTER trial provide solid evidence upon which to base recommendations for first- or second-trimester testing, or a combination of both.
Read More
Treat sudden jump in systolic blood pressure as emergency in preeclamptic patients
January 1st 2006Abiding by the old rules and waiting for a severely preeclamptic patient's diastolic blood pressure (BP) to reach or rise above 110 mm Hg before beginning to treat hypertension can invite a deadly stroke, warned a leading Jackson, Miss. maternal-fetal medicine researcher. Instead, consider treating as a hypertensive emergency a pregnant patient's sudden severe systolic BP reading of 155 to 160 mm Hg or more, regardless of the diastolic reading, said James N. Martin, Jr., MD, Professor of Obstetrics and Gynecology, and Director of Maternal-Fetal Medicine and Obstetrics at the University of Mississippi School of Medicine.
Read More
No need for pediatricians to be present at all C-sections
December 1st 2005Because there is no increased incidence of infant resuscitation during cesarean sections performed with regional anesthesia for reasons other than fetal distress or malpresentation, pediatricians need not be present, according to a recent cohort study from Australia.
Read More
A primer on breast reduction surgery
November 1st 2005Excessively large breasts can be so painful that even the rare risk of losing her nipples and areolae won't dissuade a woman from undergoing reduction surgery. This article—by two plastic surgeons—gives you information on the pros and cons of various surgical approaches so you can educate patients about all of their options.
Read More
Is pelvic floor myalgia causing your patient's dyspareunia?
October 1st 2005Proper evaluation of a key muscle group can identify pelvic floor myalgia—an often unsuspected but highly treatable cause of insertional dyspareunia and pelvic pain. An expert tells how to proceed with diagnosis and treatment.
Read More
Glyburide as effective as insulin for gestational diabetes
October 1st 2005Glyburide is as effective as insulin for women with gestational diabetes mellitus and a fasting plasma glucose of 140 mg/dL or less on a 3-hour glucose tolerance test, according to a 4-year retrospective study of a large and diverse managed-care population.
Read More